Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value |
|---|
| Revenue |
|---|
| EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $394.74 | $354.32B | $432.43B | $447.57B | $20.65B | $12.06B | 29.84x | 0.79x | 16.39x |
EL ELV Elevance Health, Inc. FY ended Feb 01, 2026 | $397.66 | $86.24B | $101.25B | $199.13B | $8.46B | $5.66B | 15.77x | 0.43x | 10.93x |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.56 | $119.66B | $250.64B | $402.07B | $9.41B | $1.77B | 67.31x | 0.30x | 20.21x |
CI CI Cigna Group FY ended Jan 30, 2026 | $278.86 | $73.69B | $142.23B | $274.90B | $10.87B | $6.29B | 12.57x | 0.27x | 13.08x |
CN CNC CENTENE CORP FY ended Feb 13, 2026 | $64.71 | $31.97B | $48.30B | $194.78B | -$4.73B | -$6.67B | -4.78x | 0.16x | — |
OS OSCR Oscar Health, Inc. FY ended Dec 31, 2025 | $30.95 | $9.29B | $10.50B | $11.70B | -$412.94M | -$443.15M | -18.31x | 0.79x | — |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 16.44x | 4/6 | $43.84B | $365.13 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 0.46x | 6/6 | $59.40B | $494.73 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 17.07x | 6/6 | $20.27B | $168.87 | Included in the active peer mix. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $394.74 | $354.32B | $432.43B | $447.57B | $20.65B | $12.06B | 29.84x | 0.79x | 16.39x |
EL ELV Elevance Health, Inc. FY ended Feb 01, 2026 | $397.66 | $86.24B | $101.25B | $199.13B | $8.46B | $5.66B | 15.77x | 0.43x | 10.93x |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.56 | $119.66B | $250.64B | $402.07B | $9.41B | $1.77B | 67.31x | 0.30x | 20.21x |
CI CI Cigna Group FY ended Jan 30, 2026 | $278.86 | $73.69B | $142.23B | $274.90B | $10.87B | $6.29B | 12.57x | 0.27x | 13.08x |
CN CNC CENTENE CORP FY ended Feb 13, 2026 | $64.71 | $31.97B | $48.30B | $194.78B | -$4.73B | -$6.67B | -4.78x | 0.16x | — |
OS OSCR Oscar Health, Inc. FY ended Dec 31, 2025 | $30.95 | $9.29B | $10.50B | $11.70B | -$412.94M | -$443.15M | -18.31x | 0.79x | — |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 16.44x | 4/6 | $43.84B | $365.13 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 0.46x | 6/6 | $59.40B | $494.73 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 17.07x | 6/6 | $20.27B | $168.87 | Included in the active peer mix. |
